475 related articles for article (PubMed ID: 11050697)
1. Effect of activated human protein C on disseminated intravascular coagulation induced by lipopolysaccharide in rats.
Aoki Y; Ota M; Katsuura Y; Komoriya K; Nakagaki T
Arzneimittelforschung; 2000 Sep; 50(9):809-15. PubMed ID: 11050697
[TBL] [Abstract][Full Text] [Related]
2. Characteristic effects of activated human protein C on tissue thromboplastin-induced disseminated intravascular coagulation in rabbits.
Katsuura Y; Aoki K; Tanabe H; Kiyoki M; Funatsu A
Thromb Res; 1994 Nov; 76(4):353-62. PubMed ID: 7871494
[TBL] [Abstract][Full Text] [Related]
3. Effect of activated human protein C on experimental venous thrombosis induced by stasis with operative invasion in mice.
Aoki Y; Fukumoto Y; Inoue K; Katsuura Y; Komoriya K; Miyamoto S
Arzneimittelforschung; 2000 Aug; 50(8):695-9. PubMed ID: 10994152
[TBL] [Abstract][Full Text] [Related]
4. Effects of two tetrahydroisoquinolines (YS-49 and YS-51) on experimental disseminated intravascular coagulation induced by lipopolysaccharide in rats.
Pyo MK; Yun-Choi HS; Chang KC; Lee DH
Arzneimittelforschung; 2004; 54(11):705-10. PubMed ID: 15612611
[TBL] [Abstract][Full Text] [Related]
5. Effect of urinary protein C inhibitor on lipopolysaccharide-induced disseminated intravascular coagulation in rats.
Fujita M; Izutani W; Komurasaki Y
Thromb Haemost; 2000 Jul; 84(1):54-8. PubMed ID: 10928470
[TBL] [Abstract][Full Text] [Related]
6. The effects of higenamine on LPS-induced experimental disseminated intravascular coagulation (DIC) in rats.
Yun-Choi HS; Pyo MK; Chang KC; Lee DH
Planta Med; 2002 Apr; 68(4):326-9. PubMed ID: 11988856
[TBL] [Abstract][Full Text] [Related]
7. The glycosaminoglycan of recombinant human soluble thrombomodulin affects antithrombotic activity in a rat model of tissue factor-induced disseminated intravascular coagulation.
Nawa K; Itani T; Ono M; Sakano K; Marumoto Y; Iwamoto M
Thromb Haemost; 1992 Mar; 67(3):366-70. PubMed ID: 1322570
[TBL] [Abstract][Full Text] [Related]
8. Effects of recombinant human soluble thrombomodulin (rhs-TM) on a rat model of disseminated intravascular coagulation with decreased levels of plasma antithrombin III.
Aoki Y; Ohishi R; Takei R; Matsuzaki O; Mohri M; Saitoh K; Gomi K; Sugihara T; Kiyota T; Yamamoto S
Thromb Haemost; 1994 Apr; 71(4):452-5. PubMed ID: 8052962
[TBL] [Abstract][Full Text] [Related]
9. Pathophysiology of disseminated intravascular coagulation (DIC) progresses at a different rate in tissue factor-induced and lipopolysaccharide-induced DIC models in rats.
Asakura H; Suga Y; Yoshida T; Ontachi Y; Mizutani T; Kato M; Ito T; Morishita E; Yamazaki M; Miyamoto K; Nakao S
Blood Coagul Fibrinolysis; 2003 Apr; 14(3):221-8. PubMed ID: 12695743
[TBL] [Abstract][Full Text] [Related]
10. Guidelines for the diagnosis and management of disseminated intravascular coagulation. British Committee for Standards in Haematology.
Levi M; Toh CH; Thachil J; Watson HG
Br J Haematol; 2009 Apr; 145(1):24-33. PubMed ID: 19222477
[TBL] [Abstract][Full Text] [Related]
11. The effect of fibrinolytic enzyme FIIa from Agkistrodon acutus venom on disseminated intravascular coagulation in rabbits.
Lin X; Liang XX; Chen JS; Chen Q; Qiu PX; Yan GM
Transl Res; 2007 Nov; 150(5):295-302. PubMed ID: 17964518
[TBL] [Abstract][Full Text] [Related]
12. [Effects of urokinase intervention on endotoxin-induced DIC in Wistar rat model].
Yuan KF; Liao XM; Yu L; Niu T; Zhang XL; Liu WP; Liao DY; Meng WT; Fei XF
Sichuan Da Xue Xue Bao Yi Xue Ban; 2010 Nov; 41(6):965-9. PubMed ID: 21265095
[TBL] [Abstract][Full Text] [Related]
13. Activated human protein C prevents thrombin-induced thromboembolism in mice. Evidence that activated protein c reduces intravascular fibrin accumulation through the inhibition of additional thrombin generation.
Gresele P; Momi S; Berrettini M; Nenci GG; Schwarz HP; Semeraro N; Colucci M
J Clin Invest; 1998 Feb; 101(3):667-76. PubMed ID: 9449701
[TBL] [Abstract][Full Text] [Related]
14. Novel recombinant fibrinogenase of Agkistrodon acutus venom protects against LPS-induced DIC.
Wang R; Cai J; Huang Y; Xu D; Sang H; Yan G
Thromb Res; 2009 Apr; 123(6):919-24. PubMed ID: 19070354
[TBL] [Abstract][Full Text] [Related]
15. Human urinary soluble thrombomodulin (MR-33) improves disseminated intravascular coagulation without affecting bleeding time in rats: comparison with low molecular weight heparin.
Takahashi Y; Hosaka Y; Imada K; Adachi T; Niina H; Watanabe M; Mochizuki H
Thromb Haemost; 1997 Apr; 77(4):789-95. PubMed ID: 9134660
[TBL] [Abstract][Full Text] [Related]
16. Effects of DX-9065a, an orally active, newly synthesized and specific inhibitor of factor Xa, against experimental disseminated intravascular coagulation in rats.
Yamazaki M; Asakura H; Aoshima K; Saito M; Jokaji H; Uotani C; Kumabashiri I; Morishita E; Ikeda T; Matsuda T
Thromb Haemost; 1994 Sep; 72(3):392-6. PubMed ID: 7855790
[TBL] [Abstract][Full Text] [Related]
17. Urinary protein C inhibitor as a therapeutic agent to disseminated intravascular coagulation (DIC): a comparison with low molecular weight heparin in rats with lipopolysaccharide-induced DIC.
Izutani W; Fujita M; Nishizawa K; Koga J
Biol Pharm Bull; 2000 Sep; 23(9):1046-50. PubMed ID: 10993202
[TBL] [Abstract][Full Text] [Related]
18. 6,7-Dihydroxy-3-phenylcoumarin inhibits thromboplastin induced disseminated intravascular coagulation.
Tunali T; Yarat A; Bulut M; Emekli N
Br J Haematol; 2004 Jul; 126(2):226-30. PubMed ID: 15238144
[TBL] [Abstract][Full Text] [Related]
19. Effect of vitamin E on endotoxin-induced disseminated intravascular coagulation in rats.
Yoshikawa T; Furukawa Y; Murakami M; Watanabe K; Kondo M
Thromb Haemost; 1982 Oct; 48(2):235-7. PubMed ID: 7179203
[TBL] [Abstract][Full Text] [Related]
20. [Inhibitory effect of activated protein C and heparin on arterial thrombosis].
Araki H
Nihon Rinsho; 1992 Feb; 50(2):408-12. PubMed ID: 1613999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
